Advertisement
Research Article Free access | 10.1172/JCI117684
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by McCaffrey, T. in: JCI | PubMed | Google Scholar
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by Pomerantz, K. in: JCI | PubMed | Google Scholar
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by Sanborn, T. in: JCI | PubMed | Google Scholar
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by Spokojny, A. in: JCI | PubMed | Google Scholar
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by Du, B. in: JCI | PubMed | Google Scholar
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by Park, M. in: JCI | PubMed | Google Scholar
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by Folk, J. in: JCI | PubMed | Google Scholar
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by Lamberg, A. in: JCI | PubMed | Google Scholar
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by Kivirikko, K. in: JCI | PubMed | Google Scholar
Department of Medicine, Cornell University Medical College, New York Hospital, New York 10021.
Find articles by Falcone, D. in: JCI | PubMed | Google Scholar
Published February 1, 1995 - More info
Restenosis occurs in 35% of patients within months after balloon angioplasty, due to a fibroproliferative response to vascular injury. These studies describe a combined fibrosuppressive/antiproliferative strategy on smooth muscle cells cultured from human primary atherosclerotic and restenotic coronary arteries and from normal rat aortas. L-Mimosine suppressed the posttranslational hydroxylation of the precursors for collagen and for eukaryotic initiation factor-5A (eIF-5A) by directly inhibiting the specific protein hydroxylases involved, prolyl 4-hydroxylase (E.C. 1.14.11.2) and deoxyhypusyl hydroxylase (E.C. 1.14.99.29), respectively. Inhibition of deoxyhypusyl hydroxylation correlated with a dose-dependent inhibition of DNA synthesis. Inhibition of prolyl hydroxylation caused a dose-dependent reduction in the secretion of hydroxyproline-containing protein and decreased the formation of procollagen types I and III. The antifibroproliferative action could not be attributed to nonspecific or toxic effects of mimosine, appeared to be selective for the hydroxylation step in the biosynthesis of the procollagens and of eIF-5A, and was reversible upon removal of the compound. The strategy of targeting these two protein hydroxylases has important implications for the pathophysiology of restenosis and for the development of agents to control fibroproliferative diseases.
Images.